Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaine anhydrous powder to reduce plasma homocysteine in patients with hyperhomocysteinemia
CTR20250419Phase 3Completed
- Sponsor
- Beijing Sili'an Pharmaceutical
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of betaine in homocystinuria (HCU), hyperhomocysteinemia, sponsored by Beijing Sili'an Pharmaceutical. Started Feb 2025; status: completed.
02
Drugs
betaine
03
Conditions
homocystinuria (HCU)hyperhomocysteinemia
Beyond the preview
Go deeper on CTR20250419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250419.